ScholarIQanswers from OpenAlex

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects

PaperCitations, authors & open-access status

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects have?

ScholarIQcitation count

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects has 175 citations in the OpenAlex counts ScholarIQ stores.

When was Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects published?

ScholarIQyear

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects has 2019 year in the ScholarIQ index.

What is the open-access status of Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects?

ScholarIQoa status

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects has hybrid oa status in the ScholarIQ index.

What is the DOI of Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects?

ScholarIQdoi

The DOI for Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects is on the source record.

What is the PMID of Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects?

ScholarIQpmid

The PMID for Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects is on the source record.

What is the OpenAlex record for Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects?

ScholarIQopenalex

The OpenAlex for Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial